Patient Guide: Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 75 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04150068
Status: ACTIVE_NOT_RECRUITING
Condition: HIV-1-infection
Phase: PHASE2, PHASE3

Where You Can Participate

This study is available at 75 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Los Angeles, California
  • • Palm Springs, California
  • • And 72 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance - Join Clinical Trial NCTNCT04150068

How to Join This Clinical Trial - NCTNCT04150068

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for HIV-1-infection. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with HIV-1-infection. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
HIV-1-infection
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04150068 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 75 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90036 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90069 - United States

Status: Contact for availability

Clinical Research Site

Palm Springs, California 92264 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95817 - United States

Status: Contact for availability

Clinical Research Site

New Haven, Connecticut 06510 - United States

Status: Contact for availability

Clinical Research Site

Washington, District of Columbia 20017 - United States

Status: Contact for availability

Clinical Research Site

DeLand, Florida 32720 - United States

Status: Contact for availability

Clinical Research Site

Fort Lauderdale, Florida 33316 - United States

Status: Contact for availability

Clinical Research Site

Fort Pierce, Florida 34982 - United States

Status: Contact for availability

Clinical Research Site

Hialeah, Florida 33016 - United States

Status: Contact for availability

And 65 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for HIV-1-infection:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships